Superior immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (inactivated). (Q42977444)

12 November 2017

title

Superior immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (inactivated). (English)

1 reference

Japanese encephalitis virus

12 November 2017

main subject

0 references

Japanese encephalitis

1 reference

based on heuristic

inferred from title

Japanese encephalitis vaccine

1 reference

1 reference

1 reference

Akiko Kikukawa

1

1 reference

12 November 2017

Yasuyuki Gomi

2

1 reference

12 November 2017

Masateru Akechi

3

1 reference

12 November 2017

Toshiyuki Onishi

4

1 reference

12 November 2017

Sadao Manabe

5

1 reference

12 November 2017

Junko Namazue

6

1 reference

12 November 2017

Isao Fuke

7

1 reference

12 November 2017

Toyokazu Ishikawa

8

1 reference

12 November 2017

Yoshinobu Okuno

9

1 reference

12 November 2017

Shigeharu Ueda

10

1 reference

12 November 2017

language of work or name

English

0 references

publication date

31 January 2012

1 reference

12 November 2017

1 reference

12 November 2017

volume

30

1 reference

12 November 2017

issue

13

1 reference

12 November 2017

page(s)

2329-2335

1 reference

Control of Japanese encephalitis--within our grasp?

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.01.054

Acute disseminated encephalomyelitis after treatment with Japanese B encephalitis vaccine (Nakayama-Yoken and Beijing strains)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.01.054

Acute disseminated encephalomyelitis after Japanese B encephalitis vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.01.054

New Japanese encephalitis vaccines: alternatives to production in mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.01.054

IMOJEV®: a Yellow fever virus-based novel Japanese encephalitis vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.01.054

Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.01.054

Immunogenicity and protective efficacy of the current inactivated Japanese encephalitis vaccine against different Japanese encephalitis virus strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.01.054

Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.01.054

WHO informal consultation on the scientific basis of specifications for production and control of inactivated Japanese encephalitis vaccines for human use, Geneva, Switzerland, 1-2 June 2006.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.01.054

Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO®) induced neutralizing antibody titers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.01.054

Antigenic comparison of envelope protein E between Japanese encephalitis virus and some other flaviviruses using monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.01.054

10.1016/J.VACCINE.2012.01.054

7 January 2021

Identifiers

DOI

1 reference

12 November 2017

1 reference